Publication:
Revitalizing female fertility: platelet-rich plasma - hype or hope?

dc.contributor.coauthorSerdaroğulları, Münevver
dc.contributor.coauthorRaad, Georges
dc.contributor.coauthorMakieva, Sofia
dc.contributor.coauthorLiperis, Georgios
dc.contributor.coauthorFraire-Zamora, Juan J.
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorÖzenci, Çiler Çelik
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:39:35Z
dc.date.issued2024
dc.description.abstractPlatelet-rich plasma (PRP) has gained popularity as an experimental tool in regenerative medicine, with potential applications in reproductive medicine. This review will assess the existing literature on the role of PRP in female fertility enhancement, focusing on ovarian rejuvenation and increased endometrial thickness. PRP is being explored as a treatment for recurrent implantation failure, primary ovarian insufficiency and poor ovarian response. While the influence of PRP on endometrial thickness and implantation success is postulated, its effectiveness remains the subject of debate due to protocol variability and unclear patient selection criteria. This narrative review includes 36 articles published before December 2022, and highlights the lack of comprehensive molecular studies examining the impact of PRP on reproductive capacity. This review underscores the importance of standardizing PRP preparation protocols in reproductive medicine. However, challenges persist, and there is a need for well-planned randomized controlled trials and a deeper understanding of the patient population that would gain the greatest benefit from PRP treatment. Clarifying these aspects is crucial to improve outcomes for low-prognosis patients undergoing assisted reproductive technology.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessBronze Open Access
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume49
dc.identifier.doi10.1016/j.rbmo.2024.103813
dc.identifier.eissn1472-6491
dc.identifier.issn1472-6483
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85195398488
dc.identifier.urihttps://doi.org/10.1016/j.rbmo.2024.103813
dc.identifier.urihttps://hdl.handle.net/20.500.14288/23054
dc.identifier.wos1251962800001
dc.keywordsPlatelet-rich plasma
dc.keywordsFemale infertility
dc.keywordsOvarian rejuvenation
dc.keywordsEndometrial thickness
dc.keywordsPremature ovarian insufficiency
dc.keywordsRecurrent implantation failure
dc.language.isoeng
dc.publisherElsevier Sci Ltd
dc.relation.ispartofReproductive Biomedicine Online
dc.subjectObstetrics and gynecology
dc.subjectReproductive biology
dc.titleRevitalizing female fertility: platelet-rich plasma - hype or hope?
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorÖzenci, Çiler Çelik
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1Research Center
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscoveryd437580f-9309-4ecb-864a-4af58309d287

Files